(Press-News.org) The implementation of acute heart attack or ST-elevation myocardial infarction (STEMI) guidelines, protocols and standing orders in Minnesota community hospitals without cardiac catheterization labs has dramatically improved since 2003, according to a scientific poster that will be presented at the American College of Cardiology (ACC) Scientific Sessions in New Orleans, April 1-3.
Since the 1990s, the American College Cardiology (ACC)/American Heart Association (AHA) STEMI guidelines recommended that all hospitals develop protocols and standing orders (reperfusion strategy, adjunctive medications, transfer criteria) for STEMI and monitor quality measures (time to treatment and adjunctive medications).
In 2003, a survey of Minnesota hospitals without cardiac catheterization labs found less than 70 percent of hospitals had any protocols and less than 50 percent had a formal quality improvement process and many were "incomplete or inadequate," explained the study's senior author Timothy D. Henry, MD, interventional cardiologist at Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis and Director of Cardiovascular Research at Minneapolis Heart Institute Foundation. He described the 2003 survey results as "surprising and a major public health problem."
However, those findings stimulated the development of several regional STEMI systems in Minnesota, including the Level 1 Heart Attack Network created by the Minneapolis Heart Institute®. "At this point, almost every hospital in the state belongs to a STEMI network due to their proliferation after 2003," Henry noted.
To compare performance since the 2003 survey results, the researchers mailed the identical survey to emergency department medical directors and nurse managers at all 108 Minnesota hospitals without cardiac catheterization labs in late 2009.
Since 2003, implementation of STEMI guidelines, protocols and standing orders in Minnesota community hospitals without cardiac catheterization labs has "dramatically improved," Henry noted, as more than 90 percent of hospitals have specific STEMI protocols. "These hospitals don't just have general protocols, but we found that they have very specific detailed protocols about medications, when to transfer these patients and what type of reperfusion therapy to use."
Compared with 2003 when 6 percent of these hospitals had protocol-specific indications for transfer to a tertiary hospital, 72 percent of hospitals now have adopted these indications. Also, 66 percent of hospitals have a formal quality improvement process for STEMI patients.
Finally, 91 percent of STEMI patients routinely transferred to a percutaneous coronary intervention (PCI) center, which also is mandated by the guidelines, compared with 59 percent in 2003.
Minnesota has the lowest cardiovascular mortality rate in the United States, and during this time period, that rate declined 50 percent from 2002 to 2009.
"This improvement was stimulated by regional STEMI systems which support the recent class I recommendation for STEMI systems of care in the 2009 focused update of the ACC/AHA guidelines," according to the study authors.
###
Minneapolis Heart Institute®
The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care. This state-of-the-art facility combines the finest in personalized patient care with sophisticated technology in a unique, family-oriented environment. The Institute's programs, a number of which are conducted in conjunction with Abbott Northwestern Hospital, address the full range of heart and vascular health needs: prevention, diagnosis, treatment and rehabilitation.
Minneapolis Heart Institute Foundation
The Minneapolis Heart Institute Foundation is dedicated to creating a world without heart disease through groundbreaking clinical research and innovative education programs. MHIF's mission is to promote and improve cardiovascular health, quality of life and longevity for all.
Protocol-driven heart attack care proves effective and contagious
2011-04-04
ELSE PRESS RELEASES FROM THIS DATE:
Serum test could identify lung cancer in people who never smoked
2011-04-04
ORLANDO, Fla. — A panel of biomarkers appears to be able to identify the presence of lung cancer in the blood samples of people who have never smoked, according to data presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
While lung cancer has long been linked to smoking, approximately one-fourth of patients with lung cancer have never smoked. Researchers are working on ways to identify the presence of lung cancer in these patients.
Charlie Birse, Ph.D., associate director of product development at Celera Corporation, and colleagues are investigating ...
Protein test detects early-stage, asbestos-related pulmonary cancer
2011-04-04
ORLANDO, Fla. — Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6.
In a blinded test performed under the auspices of the National Cancer Institute's Early Detection Research Network Biomarker Discovery Lab, the proteomic assay could detect 15 of 19 cases of malignant pleural mesothelioma that were in stage 1 or stage 2, making the test about ...
Breast milk may provide a personalized screen of breast cancer risk
2011-04-04
ORLANDO, Fla. — Breast cancer risk can be assessed by examining the epithelial cells found in breast milk, according to preliminary study results presented at the AACR 102nd Annual Meeting 2011, held April 2-6.
This screening method has the potential to provide a personalized assessment of breast cancer risk, said lead researcher Kathleen F. Arcaro, Ph.D., associate professor of veterinary and animal sciences at the University of Massachusetts Amherst. Given that roughly 80 percent of women give birth, this screen would also cover a large percentage of the female population. ...
Nicotine does not promote lung cancer growth in mouse models
2011-04-04
ORLANDO, Fla. — Nicotine at doses similar to those found in most nicotine replacements therapies did not increase lung cancer tumor incidence, frequency or size, according to results of a mouse study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
"If you take our data and combine it with epidemiological data from Europe, even in people who quit smoking and maintain the use of nicotine replacement therapy for months or years, there does not appear to be increased lung cancer incidence," said Phillip A. Dennis, M.D., Ph.D., senior investigator at ...
Aspirin may lower the risk of pancreatic cancer
2011-04-04
ORLANDO, Fla. — The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to results of a large case-control study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
Xiang-Lin Tan, Ph.D., M.D., a research fellow at Mayo Clinic in Rochester, Minn., said the findings from this large collaborative study are preliminary and do not encourage widespread use of aspirin for this purpose.
"The results are not meant to suggest everyone should start taking aspirin once monthly to reduce their risk ...
Lung cancer risk rises in the presence of HPV antibodies
2011-04-04
ORLANDO, Fla. — Researchers with the International Agency for Research on Cancer (IARC) have found that people with lung cancer were significantly more likely to have several high-risk forms of human papillomavirus (HPV) antibodies compared to those who did not have lung cancer. These results, which were presented at the AACR 102nd Annual Meeting 2011, held April 2-6, indicate that HPV antibodies are substantially increased in people with lung cancer.
Devasena Anantharaman, Ph.D., postdoctoral fellow in the Genetic Epidemiology Group at the IARC in Lyon, France, and ...
MicroRNA variations associated with earlier prostate cancer diagnosis in African-American men
2011-04-04
ORLANDO, FL (April 4, 2011) – Prostate cancer is the second leading cause of cancer-related death among American men. Yet population-wide screening programs have not reduced the number of deaths from the disease. By focusing screening programs on the men who are at greatest risk for aggressive disease or diagnosis at a young age, researchers think they could improve mortality rates and personalize the screening approach. For that reason, scientists have been looking for genetic markers to help them identify exactly which men are at high risk and require regular screening. ...
ThinkHR Joins Assurex Global as Strategic Provider
2011-04-04
ThinkHR, a leading provider of sophisticated, on-demand, Human Resources consulting services through brokers to employers, today announced a Strategic Provider alliance with Assurex Global. The alliance agreement formalizes the independent relationships which currently exist between ThinkHR and a number of Assurex Global Partner firms and further expands ThinkHR's presence and expertise within the Assurex Global network in the United States.
ThinkHR's services include HR Hotline (a phone-based HR support service staffed by live, senior-level, human resources professionals), ...
MrsP.com Releases New Video on Bullying Written by 5-Year-Old
2011-04-04
MrsP.com, the award-winning children's website, released a new video today that looks at the issue of bullying - a hot topic among politicians and educators - from a child's point of view. Created from an original story, "The Peanut Butter and Jelly Hotdog," by 5-year-old Ivy Exum of Bremerton, WA, the video offers a funny, quirky take on a serious subject.
The story was submitted to MrsP.com as an entry to its 2010 Be-A-Famous-Writer contest. Although it didn't win the contest, the story caught the eye of the website's producers, who felt it had an important message ...
New research explains autistic's exceptional visual abilities
2011-04-04
This release is available in French.
Researchers directed by Dr. Laurent Mottron at the University of Montreal's Centre for Excellence in Pervasive Development Disorders (CETEDUM) have determined that people with autism concentrate more brain resources in the areas associated with visual detection and identification, and conversely, have less activity in the areas used to plan and control thoughts and actions. This might explain their outstanding capacities in visual tasks. The team published their findings in Human Brain Mapping on April 4, 2011.
Aiming to understand ...